^Miller RJ, Kelly PH, Neumeyer JL (1976). „Aporphines. 15. Action of aporphine alkaloids on dopaminergic mechanisms in rat brain”.European Journal of Pharmacology.35(1): 77—83.PMID943290.doi:10.1016/0014-2999(76)90302-2.
^Creese I, Padgett L, Fazzini E, Lopez F (1979). „3H-N-n-propylnorapomorphine: a novel agonist ligand for central dopamine receptors”.European Journal of Pharmacology.56(4): 411—2.PMID477735.doi:10.1016/0014-2999(79)90274-7.
^Riffee WH, Wilcox RE, Smith RV (1979). „Stereotypic and hypothermic effects of apomorphine and N-n-propylnorapomorphine in mice”.European Journal of Pharmacology.54(3): 273—7.PMID570924.doi:10.1016/0014-2999(79)90086-4.
^Neumeyer JL; Reinhard JF; Dafeldecker WP; et al. (1976). „Aporphines. 14 Dopaminergic and antinociceptive activity of aporphine derivatives. Synthesis of 10-hydroxyaporphines and 10-hydroxy-N-n-propylnoraporphine”.Journal of Medicinal Chemistry.19(1): 25—9.PMID942751.doi:10.1021/jm00223a006.CS1 одржавање: Експлицитна употреба et al. (веза)
^Benassi-Benelli A, Ferrari F, Quarantotti BP (1979). „Penile erection induced by apomorphine and N-n-propyl-norapomorphine in rats”.Archives Internationales De Pharmacodynamie Et De Thérapie.242(2): 241—7.PMID44457.
